Boston, Surgi-Vision in MRI-safe pact:
This article was originally published in Clinica
Executive Summary
In a bid to provide implantable cardiac device patients with safe access to MRI scans, Boston Scientific has entered a licensing and development agreement with Surgi-Vision. The agreement will see Boston gain access to Surgi-Vision's MRI-safe technology for use in implantable cardiac devices. The two companies also have an existing agreement to develop MRI-safe neuromodulation technology. Financial terms of the partnership were not disclosed.